|
Zinc in PDB 4x2u: X-Ray Crystal Structure of the Orally Available Aminopeptidase Inhibitor, Tosedostat, Bound to the M1 Alanyl Aminopeptidase From P. FalciparumProtein crystallography data
The structure of X-Ray Crystal Structure of the Orally Available Aminopeptidase Inhibitor, Tosedostat, Bound to the M1 Alanyl Aminopeptidase From P. Falciparum, PDB code: 4x2u
was solved by
N.Drinkwater,
S.Mcgowan,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 4x2u:
The structure of X-Ray Crystal Structure of the Orally Available Aminopeptidase Inhibitor, Tosedostat, Bound to the M1 Alanyl Aminopeptidase From P. Falciparum also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the X-Ray Crystal Structure of the Orally Available Aminopeptidase Inhibitor, Tosedostat, Bound to the M1 Alanyl Aminopeptidase From P. Falciparum
(pdb code 4x2u). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total only one binding site of Zinc was determined in the X-Ray Crystal Structure of the Orally Available Aminopeptidase Inhibitor, Tosedostat, Bound to the M1 Alanyl Aminopeptidase From P. Falciparum, PDB code: 4x2u: Zinc binding site 1 out of 1 in 4x2uGo back to Zinc Binding Sites List in 4x2u
Zinc binding site 1 out
of 1 in the X-Ray Crystal Structure of the Orally Available Aminopeptidase Inhibitor, Tosedostat, Bound to the M1 Alanyl Aminopeptidase From P. Falciparum
Mono view Stereo pair view
Reference:
N.Drinkwater,
R.S.Bamert,
K.Kannan Sivaraman,
A.Paiardini,
S.Mcgowan.
X-Ray Crystal Structures of An Orally Available Aminopeptidase Inhibitor, Tosedostat, Bound to Anti-Malarial Drug Targets Pfa-M1 and Pfa-M17. Proteins 2015.
Page generated: Wed Dec 16 05:52:38 2020
ISSN: ESSN 1097-0134 PubMed: 25645579 DOI: 10.1002/PROT.24771 |
Last articlesZn in 8WB0Zn in 8WAX Zn in 8WAU Zn in 8WAZ Zn in 8WAY Zn in 8WAV Zn in 8WAW Zn in 8WAT Zn in 8W7M Zn in 8WD3 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |